ARCHIVED Skip navigation.PDF Version     To Publications Page     To Home Page


Philadelphia/Camden High Intensity Drug Trafficking Area Drug Market Analysis 2010

Publication Date: April 2010

Document ID: 2010-R0813-027Cover image of the Philadelphia/Camden HIDTA Drug Market Analysis 2010.

Archived on: September 1, 2011. This document may contain dated information. It remains available to provide access to historical materials.

This assessment is an outgrowth of a partnership between the NDIC and HIDTA Program for preparation of annual assessments depicting drug trafficking trends and developments in HIDTA Program areas. The report has been coordinated with the HIDTA, is limited in scope to HIDTA jurisdictional boundaries, and draws upon a wide variety of sources within those boundaries.

Your questions, comments, and suggestions for future subjects are welcome at any time. Addresses are provided at the end of the page.


Strategic Drug Threat Developments

HIDTA Overview

Drug Threat Overview

Drug Trafficking Organizations




Drug-Related Crime


Illicit Finance



List of Figures

Figure 1. Philadelphia/Camden High Intensity Drug Trafficking Area

List of Tables

Table 1. Drug Seizures in the Philadelphia/Camden HIDTA, in Kilograms, 2009
Table 2. Drug Distribution Activities in the Philadelphia/Camden HIDTA, 2009

Strategic Drug Threat Developments

Cocaine (particularly crack) poses the principal drug threat in the Philadelphia/Camden High Intensity Drug Trafficking Area (PC HIDTA) region because of high levels of abuse and the violence attendant to street gang distribution of the drug. Heroin, marijuana, and controlled prescription drugs (CPDs) are also significant threats to the region.

The following are significant strategic drug threat developments in the PC HIDTA region:

To Top      To Contents


National Drug Intelligence Center
319 Washington Street, 5th Floor
Johnstown, PA 15901-1622

Tel. (814) 532-4601
FAX (814) 532-4690
E-mail NDIC.Contacts@usdoj.gov


Office of Policy and Interagency Affairs
U.S. Department of Justice
Robert F. Kennedy Building, Room 3341
950 Pennsylvania Avenue, NW
Washington, D.C. 20530-2000

Telephone: (202) 532-4040
FAX (202) 514-4252

Web Addresses

ADNET:  http://ndicosa.adnet.sgov.gov
DOJ:  http://www.justice.gov/archive/ndic/
LEO:  https://www.leo.gov/http/leowcs.leopriv.gov/lesig/archive/ndic/index.htm
RISS:  ndic.riss.net


a. Benzodiazepines, hydrocodone, fentanyl, methadone, and oxycodone.

To Top     To Contents     To Next Page

To Publications Page     To Home Page


End of page.